These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21857933)

  • 1. Association of NT-proBNP and multiple biomarkers with severity of angiographic coronary artery disease in diabetic and pre-diabetic Chinese patients.
    Fang Z; Zhou L; Bao Y; Ding W; Shi H; Luo X; Hu R
    PLoS One; 2011; 6(8):e22563. PubMed ID: 21857933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
    Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
    Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
    Hamano K; Abe M; Komi R; Kobayashi S
    Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study.
    Liu HH; Cao YX; Jin JL; Guo YL; Zhu CG; Wu NQ; Gao Y; Zhang Y; Xu RX; Dong Q; Li JJ
    Cardiovasc Diabetol; 2021 Apr; 20(1):84. PubMed ID: 33888145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
    Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
    Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide.
    Börekçi A; Gür M; Özaltun B; Baykan AO; Harbalioğlu H; Seker T; Sen Ö; Acele A; Gözükara MY; Kuloğlu O; Koç M; Çayli M
    Coron Artery Dis; 2014 Dec; 25(8):685-90. PubMed ID: 25004239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
    Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
    Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction.
    Wu N; Ma F; Guo Y; Li X; Liu J; Qing P; Xu R; Zhu C; Jia Y; Liu G; Dong Q; Jiang L; Li J
    Chin Med J (Engl); 2014; 127(4):627-32. PubMed ID: 24534213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.
    Börekçi A; Gür M; Şeker T; Baykan AO; Özaltun B; Karakoyun S; Karakurt A; Türkoğlu C; Makça I; Çaylı M
    Perfusion; 2015 Sep; 30(6):457-64. PubMed ID: 25358476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Links between sleep disordered breathing, coronary atherosclerotic burden, and cardiac biomarkers in patients with stable coronary artery disease.
    Inami T; Seino Y; Otsuka T; Yamamoto M; Kimata N; Murakami D; Takano M; Ohba T; Ibuki C; Mizuno K
    J Cardiol; 2012 Sep; 60(3):180-6. PubMed ID: 22525967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
    Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide level is depressed in patients with significant coronary artery disease who have high body mass index.
    Hong SN; Ahn Y; Yoon NS; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Int Heart J; 2008 Jul; 49(4):403-12. PubMed ID: 18753724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention.
    Pan R
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide is associated with severity of the coronary lesions in unstable angina patients with preserved left ventricular function.
    Wei G; Ningfu W; Xianhua Y; Liang Z; Jianmin Y; Guoxin T; Peng X
    J Interv Cardiol; 2012 Apr; 25(2):126-31. PubMed ID: 22150844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity troponin T level and angiographic severity of coronary artery disease.
    Ndrepepa G; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2011 Sep; 108(5):639-43. PubMed ID: 21676369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?
    Kragelund C; Grønning B; Omland T; Køber L; Strande S; Steffensen R; Hildebrandt P
    Am Heart J; 2006 Mar; 151(3):712.e1-712.e7. PubMed ID: 16504637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.